Skip to main content

Table 4 Bevacizumab possibly related adverse events

From: Front-line Bevacizumab in combination with Oxaliplatin, Leucovorin and 5-Fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study

  Grade        
  1 2 3 4
  n % n % n % n %
Pulmonary embolism - - - - - - 1 1.9
Cardiac ischaemia - - - - 1 1.9 - -
Epistaxis 4 7.6 1 1.9     
Gastrointestinal bleeding - - - - 1 1.9 - -
Hypertension 5 9.5 2 3.8 - - -  
Proteinuria 7 13.2 4 7.6 - - - -